Pressure sore risk validating an assessment tool
No other studies reported measures of reliability in the published reports. A clinical trial of the Braden Scale for predicting pressure sore risk.
Nevertheless, prevalence rates in the ICU remained the highest among hospitalized patients, ranging from 9% to 42%.3-5 In 2009, 3.3% of critical care patients developed deep tissue injuries or stage III, IV, or unstageable ulcers.5 Pressure ulcer prevention has long been a major focus of patient care. Prevention and early detection of pressure ulcers in hospitalized patients: commentary. In order to more precisely quantify risk in the critically ill population, modification of the Braden Scale or development of a critical care specific risk assessment tool may be indicated. Nutritional interventions for preventing and treating pressure ulcers. Pressure ulcers (PUs) are encountered in all care settings, including the intensive care unit (ICU), and are described as perhaps the most underrated condition within this care setting.1 Despite implementation of evidence-based preventive interventions, hospital-acquired PUs continue to be a major healthcare concern. A summary of the studies included in this review can be found in Table 1. Validation of pressure ulcer risk assessment scales: a critique. The Braden Scale for Predicting Pressure Sore Risk10 measures cumulative risk for PU development based on 7 risk factors measured on 6 subscales (Sensory Perception, Activity, Mobility, Moisture, Nutrition, and Friction/Shear) and is based on the conceptual schema developed by Braden and Bergstrom.27 Subscale scores range from 1 to 4 with the exception of the Friction/Shear subscale, which ranges from 1 to 3.
Nevertheless, there is a lack of consensus regarding which of these factors poses the greatest risk for pressure ulceration.